Hemangioma is a commonly benign tumour for infants and children. This tumor is characterized by high incidence and considerable detriment. Along with the development of molecular biology, many scholars have been researching the pathogenesis through cell, cell factor, gene, estrogen, protease and its inhibitor. This article reviews the investigative progression of this area.
